Quantcast

Latest Renal cell carcinoma Stories

2012-05-23 05:37:19

(Ivanhoe Newswire) — A new study shows that magnetic resonance imaging (MRI), when compared with clinical examination, can actually give an earlier indication of a breast tumor´s response to pre-surgical chemotherapy. Research shows that women who receive chemotherapy before surgery, known as neoadjuvant chemotherapy, are more likely to achieve breast conservation compared with those receiving chemotherapy after surgery. Traditionally, clinicians monitor the patient´s...

2012-05-17 23:03:57

Mount Sinai School of Medicine researchers will present several landmark studies, including data on treatment trends in late-stage cancer, HPV-positive head and neck cancer, a promising multiple myeloma vaccine, and predictive models of soft tissue sarcomas, prostate and bladder cancer, at the 2012 American Society of Clinical Oncology (ASCO) meeting June 1-5, 2012 in Chicago. New York, NY (PRWEB) May 17, 2012 Mount Sinai School of Medicine researchers will present several landmark studies,...

2012-05-17 14:18:12

Landmark research presented at annual cancer meeting Mount Sinai School of Medicine researchers will present several landmark studies, including data on treatment trends in late-stage cancer, a promising multiple myeloma vaccine, and predictive models of soft tissue sarcomas, prostate and bladder cancer, at the 2012 American Society of Clinical Oncology (ASCO) meeting June 1-5, 2012 in Chicago. Highlights of Mount Sinai research at ASCO: Age, Race, Lower Income, and Lack of...

2012-05-03 15:11:39

Presentations at the 4th IMPAKT Breast Cancer Conference A new analysis may help doctors identify breast cancer patients who will benefit from treatment with the immune suppressant drug everolimus, say French researchers at the 4th IMPAKT Breast Cancer Conference in Brussels, Belgium. Everolimus is currently used as an immunosuppressant to prevent patients rejecting transplanted organs and in the treatment of renal cell cancer. Research is also being conducted into the drug's use in...

2012-03-29 22:10:17

Patients with papillary renal cell carcinoma, the second most common kidney cancer subtype, face a low risk of tumor recurrence and cancer-related death after surgery. Those are the key findings of a multi-centre study of nearly 600 patients published in the April issue of the urology journal BJUI. "Because papillary renal cell carcinoma (pRCC) only affects ten to 15% of kidney cancer patients, the small number of patients enrolled in individual studies makes it hard to draw meaningful...

2012-03-02 14:04:34

2 studies published online today in the same issue of journal Cell BGI, the world's largest genomics organization, developed single-cell genome sequencing technology and published two research papers for cancer single-cell sequencing in the research journal Cell. In the papers, which were published today in the same issue of Cell, BGI researchers applied their new single-cell sequencing (SCS) method to identify the genetic characteristics of essential thrombocythemia (ET, a kind of blood...

2012-02-20 11:47:25

Penn oncologist presents results of new approach to fighting cancer at annual AAAS meeting Blocking autophagy -- the process of "self-eating" within cells -- is turning out to be a viable way to enhance the effectiveness of a wide variety of cancer treatments. Specifically, blocking the action of an acidic inner cell part, which acts like a stomach and chews up proteins for recycling, is the main attack strategy, says Ravi K. Amaravadi, MD, an assistant professor of Medicine at the...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.